| __timestamp | Ionis Pharmaceuticals, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20140000 | 1244910 |
| Thursday, January 1, 2015 | 37173000 | 5029636 |
| Friday, January 1, 2016 | 48616000 | 4846776 |
| Sunday, January 1, 2017 | 108488000 | 5329003 |
| Monday, January 1, 2018 | 244622000 | 7121000 |
| Tuesday, January 1, 2019 | 287000000 | 9128000 |
| Wednesday, January 1, 2020 | 354000000 | 10731000 |
| Friday, January 1, 2021 | 186000000 | 10701000 |
| Saturday, January 1, 2022 | 151000000 | 16121000 |
| Sunday, January 1, 2023 | 232600000 | 37021000 |
Unleashing insights
In the dynamic world of biotechnology, understanding financial trends is crucial. Over the past decade, Ionis Pharmaceuticals and Viking Therapeutics have shown contrasting trajectories in their Selling, General, and Administrative (SG&A) expenses. Ionis Pharmaceuticals, a leader in RNA-targeted therapeutics, saw its SG&A expenses skyrocket by over 1,000% from 2014 to 2023, peaking in 2020. This reflects their aggressive expansion and investment in research and development. In contrast, Viking Therapeutics, a smaller player focusing on metabolic and endocrine disorders, experienced a more modest increase of around 2,900% in the same period, with a significant jump in 2023. This suggests a strategic shift or new product launches. These trends highlight the differing strategies and market positions of these two companies, offering valuable insights for investors and industry analysts.
Novartis AG and Viking Therapeutics, Inc.: SG&A Spending Patterns Compared
Biogen Inc. vs Ionis Pharmaceuticals, Inc.: SG&A Expense Trends
Insmed Incorporated or Viking Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Viking Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Ionis Pharmaceuticals, Inc. and Perrigo Company plc
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. and ImmunityBio, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Viking Therapeutics, Inc. and Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Viking Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Comparing SG&A Expenses: Viking Therapeutics, Inc. vs MannKind Corporation Trends and Insights
Operational Costs Compared: SG&A Analysis of Viking Therapeutics, Inc. and Xencor, Inc.